Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBTB7C antisense RNA 2 (ZBTB7C-AS2) is a long non-coding RNA gene located on human chromosome 18 and is transcribed in the antisense orientation relative to the ZBTB7C gene. Antisense RNAs, such as ZBTB7C-AS2, generally act via RNA-mediated mechanisms to regulate the transcription, stability, or translation of their sense partner gene (in this case, ZBTB7C)—a proto-oncoprotein with roles in cell cycle, metabolism, and transcriptional repression. While the broader class of antisense RNAs can be involved in a variety of regulatory processes in mammals, including chromatin modification and gene silencing, there is currently no evidence in the provided literature that ZBTB7C-AS2 itself is a therapeutic target, biomarker, or directly implicated in human disease pathogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZBTB7C antisense RNA 2 (ZBTB7C-AS2).